非甾体抗炎药和柳氮磺吡啶是基本治疗药物。
Nonsteroidal anti-inflammatory drugs and sulfasalazine were the mainstay of treatment.
甲氨喋呤加柳氮磺吡啶疗法是推荐给那些患病时间长久，病情高度活动、但是没有不良预后特征的患者。
Methotrexate plus sulfasalazine is recommended in patients with all disease durations provided they have high disease activity and poor prognostic features.
柳氮磺吡啶单一疗法为那些长期患有各种疾病和没有不良预后特征的，包含那些不同严重程度患病的患者推荐。
Sulfasalazine monotherapy is recommended for patients with all disease durations and without poor prognostic features and includes those with all degrees of disease activity.
在进行手术前(除急诊外)，应尝试使用药物如柳氮磺吡啶、激素、硫唑嘌呤、肿瘤坏死因子拮抗剂及反应停。
Agents such as sulfasalazine, corticosteroids, azathioprine, TNFa antagonists and thalidomide should be tried first before surgery, except in emergencies.
羟氯喹加柳氮磺吡啶疗法是只推荐给那些患病时间中等(6 -24个月)，病情重但是没有不良预后特征的患者。
Hydroxychloroquine plus sulfasalazine is recommended only for patients with intermediate disease duration (6-24 months) and high disease activity but without poor prognostic features.
羟氯喹加柳氮磺吡啶疗法是只推荐给那些患病时间中等(6 -24个月)，病情重但是没有不良预后特征的患者。
Hydroxychloroquine plus sulfasalazine is recommended only for patients with intermediate disease duration (6-24 months) and high disease activity but without poor prognostic features.
应用推荐